A multicenter, randomized trial comparing efficacy and safety of paclitaxel/capecitabine and cisplatin/capecitabine in advanced gastric cancer.

Zhihao LuXiaotian ZhangWei LiuTianshu LiuBing HuWei LiQingxia FanJianming XuNong XuYuxian BaiYueyin PanQing XuWei BaiLi XiaYong GaoWenling WangYongqian ShuLin Shen

Published in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2018)

First-line chemotherapy with PACX is effective with milder toxicities in advanced gastric cancer, but could not replace XP.

Keyphrases

locally advanced
neoadjuvant chemotherapy
rectal cancer
phase ii study
squamous cell carcinoma
radiation therapy
metastatic breast cancer
metastatic colorectal cancer
phase iii
cross sectional
double blind
randomized controlled trial
clinical trial
study protocol